Likewise, studies should be carried out to look at the affinity and efficacy of commonplace SCBs performing at likely cellular targets other than CBRs, like adrenergic, serotonergic and glutaminergic receptors. Adverse outcomes made by SCBs are not likely to consequence from impurities incurred thro